Breast-imaging reporting and tracking system developer Ikonopedia has announced the addition of contrast-enhanced mammography (CEM) to its offerings.
CEM is valuable for evaluating abnormalities, staging cancer, monitoring treatment response, and screening high-risk patients. CEM tracking and analytics offers greater consistency in documentation and patient follow-through across all imaging modalities, according to the company. It offers an alternative to breast MRI that improves cancer detection, particularly in women with dense breast tissue.
